216 related articles for article (PubMed ID: 11750944)
1. Estimation of pharmacokinetic parameters by orthogonal regression: comparison of four algorithms.
Tod M; Aouimer A; Petitjean O
Comput Methods Programs Biomed; 2002 Jan; 67(1):13-26. PubMed ID: 11750944
[TBL] [Abstract][Full Text] [Related]
2. Estimation of population pharmacokinetic parameters in the presence of non-compliance.
Mu S; Ludden TM
J Pharmacokinet Pharmacodyn; 2003 Feb; 30(1):53-81. PubMed ID: 12800807
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokinetics.
Tod M; Rocchisani JM
J Pharmacokinet Biopharm; 1997 Aug; 25(4):515-37. PubMed ID: 9561492
[TBL] [Abstract][Full Text] [Related]
4. [Effects of multiple-trough sampling design and algorithm on the estimation of population and individual pharmacokinetic parameters].
Ling J; Qian LX; Ding JJ; Jiao Z
Yao Xue Xue Bao; 2014 May; 49(5):686-94. PubMed ID: 25151742
[TBL] [Abstract][Full Text] [Related]
5. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
6. Numerical estimation of the noncompartmental pharmacokinetic parameters variance and coefficient of variation of residence times.
Purves RD
J Pharm Sci; 1994 Feb; 83(2):202-5. PubMed ID: 8169789
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm--a retrospective study.
Terziivanov D; Atanasova I; Dimitrova V
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):376-82. PubMed ID: 9707352
[TBL] [Abstract][Full Text] [Related]
8. Investigating the contribution of residual unexplained variability components on bias and imprecision of parameter estimates in population pharmacokinetic mixed-effects modeling.
Jaber MM; Brundage RC
J Pharmacokinet Pharmacodyn; 2023 Apr; 50(2):123-132. PubMed ID: 36617366
[TBL] [Abstract][Full Text] [Related]
9. Application of direct search optimization for pharmacokinetic parameter estimation.
Khorasheh F; Sattari S; Gerayeli A; Ahmadi AM
J Pharm Pharm Sci; 1999; 2(3):92-8. PubMed ID: 10953255
[TBL] [Abstract][Full Text] [Related]
10. On the recording of sample times and parameter estimation from repeated measures pharmacokinetic data.
Sun H; Ette EI; Ludden TM
J Pharmacokinet Biopharm; 1996 Dec; 24(6):637-50. PubMed ID: 9300354
[TBL] [Abstract][Full Text] [Related]
11. Application of fast orthogonal search to linear and nonlinear stochastic systems.
Chon KH; Korenberg MJ; Holstein-Rathlou NH
Ann Biomed Eng; 1997; 25(5):793-801. PubMed ID: 9300103
[TBL] [Abstract][Full Text] [Related]
12. Assessment of type I error rates for the statistical sub-model in NONMEM.
Wählby U; Bouw MR; Jonsson EN; Karlsson MO
J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):251-69. PubMed ID: 12449498
[TBL] [Abstract][Full Text] [Related]
13. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
Knights J; Rohatagi S
J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
[TBL] [Abstract][Full Text] [Related]
14. Fuzzy least squares for identification of individual pharmacokinetic parameters.
Seng KY; Nestorov I; Vicini P
IEEE Trans Biomed Eng; 2009 Dec; 56(12):2796-805. PubMed ID: 19695981
[TBL] [Abstract][Full Text] [Related]
15. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
[TBL] [Abstract][Full Text] [Related]
16. Approaches to handling pharmacodynamic baseline responses.
Dansirikul C; Silber HE; Karlsson MO
J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):269-83. PubMed ID: 18446428
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4.
Bouillon-Pichault M; Jullien V; Bazzoli C; Pons G; Tod M
J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):25-40. PubMed ID: 21046208
[TBL] [Abstract][Full Text] [Related]
18. Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building.
Sherer EA; Sale ME; Pollock BG; Belani CP; Egorin MJ; Ivy PS; Lieberman JA; Manuck SB; Marder SR; Muldoon MF; Scher HI; Solit DB; Bies RR
J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):393-414. PubMed ID: 22767341
[TBL] [Abstract][Full Text] [Related]
19. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
Mentré F; Mallet A; Steimer JL
Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of ciprofloxacin in pediatric patients.
Rajagopalan P; Gastonguay MR
J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
